1. Home
  2. FTCI vs KZIA Comparison

FTCI vs KZIA Comparison

Compare FTCI & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo FTC Solar Inc.

FTCI

FTC Solar Inc.

HOLD

Current Price

$4.37

Market Cap

122.4M

Sector

Technology

ML Signal

HOLD

Logo Kazia Therapeutics Limited

KZIA

Kazia Therapeutics Limited

HOLD

Current Price

$11.99

Market Cap

100.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTCI
KZIA
Founded
2017
1994
Country
United States
Australia
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
122.4M
100.8M
IPO Year
2021
2002

Fundamental Metrics

Financial Performance
Metric
FTCI
KZIA
Price
$4.37
$11.99
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
4
Target Price
$10.80
$19.50
AVG Volume (30 Days)
193.1K
228.4K
Earning Date
05-01-2026
06-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$99,687,000.00
N/A
Revenue This Year
$65.44
N/A
Revenue Next Year
$45.97
N/A
P/E Ratio
N/A
N/A
Revenue Growth
110.51
N/A
52 Week Low
$3.21
$3.30
52 Week High
$12.75
$17.40

Technical Indicators

Market Signals
Indicator
FTCI
KZIA
Relative Strength Index (RSI) 45.98 48.35
Support Level $3.30 $5.71
Resistance Level $5.31 $14.82
Average True Range (ATR) 0.54 1.05
MACD 0.01 -0.31
Stochastic Oscillator 50.36 8.31

Price Performance

Historical Comparison
FTCI
KZIA

About FTCI FTC Solar Inc.

FTC Solar Inc is a provider of solar tracker systems, supported by proprietary software and value-added engineering services. The company's Solar tracker systems move solar panels throughout the day to maintain an optimal orientation relative to the sun, thereby increasing the amount of solar energy produced at a solar installation. It focuses on providing differentiated products, software, and services that maximize energy generation. The company has launched a new mounting solution to support the installation and use of U.S. manufactured thin-film modules by project owners. The only segment the company is engaged in is the Manufacturing and Servicing of Solar tracker systems.

About KZIA Kazia Therapeutics Limited

Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.

Share on Social Networks: